Tarceva: Oral tablet (100mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
What is this Medicine?
ERLOTINIB (er LOE ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat non-small cell lung cancer and pancreatic cancer.
Tarceva 100mg Tablet
NDC: 502420063-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer
Sometimes used for but not FDA approved for the following conditions:
Head And Neck Cancer
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Reported Side Effects for Tarceva 100mg Tablet
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.



Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


